TY - JOUR
T1 - A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen
AU - Impagliazzo, Antonietta
AU - Milder, Fin
AU - Kuipers, Harmjan
AU - Wagner, Michelle V
AU - Zhu, Xueyong
AU - Hoffman, Ryan M B
AU - van Meersbergen, Ruud
AU - Huizingh, Jeroen
AU - Wanningen, Patrick
AU - Verspuij, Johan
AU - de Man, Martijn
AU - Ding, Zhaoqing
AU - Apetri, Adrian
AU - Kükrer, Başak
AU - Sneekes-Vriese, Eveline
AU - Tomkiewicz, Danuta
AU - Laursen, Nick S
AU - Lee, Peter S
AU - Zakrzewska, Anna
AU - Dekking, Liesbeth
AU - Tolboom, Jeroen
AU - Tettero, Lisanne
AU - van Meerten, Sander
AU - Yu, Wenli
AU - Koudstaal, Wouter
AU - Goudsmit, Jaap
AU - Ward, Andrew B
AU - Meijberg, Wim
AU - Wilson, Ian A
AU - Radošević, Katarina
N1 - Copyright © 2015, American Association for the Advancement of Science.
PY - 2015/8/24
Y1 - 2015/8/24
N2 - The identification of human broadly neutralizing antibodies (bnAbs) targeting the hemagglutinin (HA) stem revitalized hopes of developing a universal influenza vaccine. Using a rational design and library approach, we engineered stable HA stem antigens ("mini-HAs") based on an H1 subtype sequence. Our most advanced candidate exhibits structural and bnAb binding properties comparable to those of full-length HA, completely protects mice in lethal heterologous and heterosubtypic challenge models, and reduces fever after sublethal challenge in cynomolgus monkeys. Antibodies elicited by this mini-HA in mice and nonhuman primates bound a wide range of HAs, competed with human bnAbs for HA stem binding, neutralized H5N1 viruses, and mediated antibody-dependent effector activity. These results represent a proof of concept for the design of HA stem mimics that elicit bnAbs against influenza A group 1 viruses.
AB - The identification of human broadly neutralizing antibodies (bnAbs) targeting the hemagglutinin (HA) stem revitalized hopes of developing a universal influenza vaccine. Using a rational design and library approach, we engineered stable HA stem antigens ("mini-HAs") based on an H1 subtype sequence. Our most advanced candidate exhibits structural and bnAb binding properties comparable to those of full-length HA, completely protects mice in lethal heterologous and heterosubtypic challenge models, and reduces fever after sublethal challenge in cynomolgus monkeys. Antibodies elicited by this mini-HA in mice and nonhuman primates bound a wide range of HAs, competed with human bnAbs for HA stem binding, neutralized H5N1 viruses, and mediated antibody-dependent effector activity. These results represent a proof of concept for the design of HA stem mimics that elicit bnAbs against influenza A group 1 viruses.
KW - animals
KW - antibodies, neutralizing/immunology
KW - antibodies, viral/immunology
KW - hemagglutinin glycoproteins, influenza virus/chemistry
KW - humans
KW - influenza A virus, H1N1 subtype/immunology
KW - influenza A virus, H5N1 subtype/immunology
KW - influenza vaccines/immunology
KW - influenza, human/prevention & control
KW - mice
KW - protein multimerization
KW - protein structure, secondary
KW - dieren
KW - antilichamen, neutraliserend/immunologie
KW - antilichamen, virale/immunologie
KW - hemagglutinineglycoproteïnen, influenzavirus/chemie
KW - mensen
KW - influenza A-virus, H1N1-subtype/immunologie
KW - influenza A-virus, H5N1-subtype/immunologie
KW - griepvaccins/immunologie
KW - griep, mensen/preventie & controle
KW - muizen
KW - multimerisatie van eiwitten
KW - eiwitstructuur, secundair
U2 - 10.1126/science.aac7263
DO - 10.1126/science.aac7263
M3 - Article
C2 - 26303961
SN - 0036-8075
VL - 349
SP - 1301
EP - 1306
JO - Science (New York, N.Y.)
JF - Science (New York, N.Y.)
IS - 6254
ER -